HC Wainwright reiterated their buy rating on shares of Atreca (NASDAQ:BCEL – Get Rating) in a report released on Thursday, Benzinga reports. HC Wainwright currently has a $25.00 price objective on the stock. A number of other analysts have also commented on BCEL. Wedbush reissued an outperform rating and set a $4.00 price target on […]
Related Keywords
Robert Axtell , Jeremy Sokolove , Renaissance Technologies , Atreca Inc , Ef Hutton Acquisition Co , Ensign Peak Advisors Inc , Millennium Management , Get Rating , Brookline Capital Management , Trading Down , Capital Management , Peak Advisors Inc , Exoduspoint Capital Management , Guy Cavet , Atreca Daily , Atreca , Nasdaq Bcel , Nbcel , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.